Browsing Tag
BiPASS
1 post
Telix Pharmaceuticals wins FDA Fast Track for BiPASS as prostate imaging moves before biopsy
Telix Pharmaceuticals Limited has received FDA Fast Track designation for its BiPASS programme, advancing a strategy that combines PSMA-PET and MRI before prostate biopsy as the company prepares a planned US regulatory submission.
October 2, 2026